Literature DB >> 9744703

Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature.

A Grieco1, F M Vecchio, A V Greco, G Gasbarrini.   

Abstract

A 72-year-old housewife presented with clinical and laboratory signs of acute cholestatic hepatitis. Symptoms had appeared 6 months after she was started on ticlopidine 250 mg/day. Infectious aetiologies were excluded by serology and there was no history of alcohol abuse or use of other drugs. Clinical findings were confirmed by liver biopsy. The drug was discontinued and symptoms gradually subsided. A second biopsy obtained during this phase documented complete resolution of the hepatic damage. A review of the literature shows that the late onset of hepatic toxicity in this case is unique and this is the first report to include histological documentation during the acute phase and after recovery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744703

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4.

Authors:  Jyothi C Talakad; Manish B Shah; Gregory S Walker; Cathie Xiang; James R Halpert; Deepak Dalvie
Journal:  Drug Metab Dispos       Date:  2010-12-14       Impact factor: 3.922

2.  A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.

Authors:  Pedro Zapater; José Such; Miguel Pérez-Mateo; José Francisco Horga
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report.

Authors:  Antonino M Previtera; Rossella Pagani
Journal:  J Med Case Rep       Date:  2010-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.